Skip to main content
Erschienen in: Supportive Care in Cancer 4/2009

01.04.2009 | Original Article

Overall information needs of early-stage prostate cancer patients over a decade: highly variable and remarkably stable

verfasst von: Deb Feldman-Stewart, Sarah Brennenstuhl, Michael D. Brundage, D. Robert Siemens

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the stability of information needs of early-stage prostate cancer patients by comparing needs in the same location, at two time points, almost 10 years apart.

Method

Two groups of patients were surveyed (first, 1996; second, 2005) to identify retrospectively their information needs in the diagnosis-to-treatment-decision time interval. Both sampling cohorts were men diagnosed in one location in Canada within the previous 2 years. Participants rated the importance of getting answers to each of 92 questions (organized in eight categories) using four options: essential, desired, no opinion, or avoid. For each essential and desired question, respondents also indicated the reason(s) they wanted the question addressed: to understand, decide, plan, or other.

Results

The two groups had similar response rates: 38 (68%) in 1996 and 130 (70%) in 2005. They also had similar ages, marital status, or education. Both groups rated means of: 49 questions “essential” with wide ranges across respondents (12–90 vs 0–92 questions); 73 questions as “essential”/“desired”; and two questions to “avoid”. At both times, every question was essential to some participants but only six (in 1996) and 12 (in 2005) questions were essential to over 80% of participants. In both groups, the most frequent reason for essential questions was for understanding (mean number of questions 34 vs 36), followed by decision making (means 13 vs 19), and then planning (means 10 vs 15).

Conclusions

We have demonstrated reliably that, although many patients want a lot of information, the range in amount and in exact details varies considerably across individuals. Systematic patient education is needed, therefore, but it must be individualized.
Literatur
1.
Zurück zum Zitat SPSS (16.0) (2008) Chicago, Illinois, SPSS Inc. SPSS (16.0) (2008) Chicago, Illinois, SPSS Inc.
2.
Zurück zum Zitat Appelbaum PS, Lidz CW, Meisel A (1987) Informed consent: legal theory and clinical practice. Oxford University Press, New York Appelbaum PS, Lidz CW, Meisel A (1987) Informed consent: legal theory and clinical practice. Oxford University Press, New York
5.
Zurück zum Zitat Brundage M, Lukka H, Crook J, Warde P, Bauman G, Catton C, Markman BR, Charette M, Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease site Group (2002) The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer—a systematic review. Radiother Oncol 64:239–250. doi:10.1016/S0167-8140(02)00184-6 PubMedCrossRef Brundage M, Lukka H, Crook J, Warde P, Bauman G, Catton C, Markman BR, Charette M, Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease site Group (2002) The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer—a systematic review. Radiother Oncol 64:239–250. doi:10.​1016/​S0167-8140(02)00184-6 PubMedCrossRef
6.
Zurück zum Zitat Caffo D, Fellin G, Graffer U, Luciani L (1996) Assessment of quality of life after radical radiotherapy for prostate cancer. Br J Urol 78:557–563PubMed Caffo D, Fellin G, Graffer U, Luciani L (1996) Assessment of quality of life after radical radiotherapy for prostate cancer. Br J Urol 78:557–563PubMed
7.
Zurück zum Zitat Carolan H, Parsons C, Feldman-Stewart D, Botorff J (2008) Determining the information necessary for patient treatment decisions in ductal carcinoma in situ of the breast (DCIS). Canadian Association of Radiation Oncology, Montreal Canada, September 2008, (Abstract) Carolan H, Parsons C, Feldman-Stewart D, Botorff J (2008) Determining the information necessary for patient treatment decisions in ductal carcinoma in situ of the breast (DCIS). Canadian Association of Radiation Oncology, Montreal Canada, September 2008, (Abstract)
8.
Zurück zum Zitat Crook J, Lukka H, Klotz L, Bestic N, Johnston M, Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative (2000) Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer. CMAJ 164:975–981 Crook J, Lukka H, Klotz L, Bestic N, Johnston M, Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative (2000) Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer. CMAJ 164:975–981
12.
Zurück zum Zitat Dillman DA (1978) Implementing mail surveys. In: Mail and telephone surveys: the total design method. Wiley, New York, NY, pp 160–199 Dillman DA (1978) Implementing mail surveys. In: Mail and telephone surveys: the total design method. Wiley, New York, NY, pp 160–199
13.
Zurück zum Zitat Dunn J, Steginga S, Occhipinti S, McCaffrey J, Collins DM (1999) Men's preferences for sources of information about support for cancer. J Cancer Educ 14:238–242 Dunn J, Steginga S, Occhipinti S, McCaffrey J, Collins DM (1999) Men's preferences for sources of information about support for cancer. J Cancer Educ 14:238–242
14.
Zurück zum Zitat Feldman-Stewart D, Brennenstuhl S, Brundage M (2008) The information needed by Canadian early-stage prostate cancer patients for decision-making: Stable over a decade. Patient Educ Couns, doi:10.1016/j.pec.2008.07.008 Feldman-Stewart D, Brennenstuhl S, Brundage M (2008) The information needed by Canadian early-stage prostate cancer patients for decision-making: Stable over a decade. Patient Educ Couns, doi:10.​1016/​j.​pec.​2008.​07.​008
17.
Zurück zum Zitat Feldman-Stewart D, Brundage MD, Siemens R, Skarsgard D (2006) A randomized controlled trial comparing two educational booklets on prostate cancer. Can J Urol 13:3321–3326PubMed Feldman-Stewart D, Brundage MD, Siemens R, Skarsgard D (2006) A randomized controlled trial comparing two educational booklets on prostate cancer. Can J Urol 13:3321–3326PubMed
19.
20.
Zurück zum Zitat Feldman-Stewart D, Capirci C, Brennenstuhl S, Abacioglu U, Gawkowska-Suwinska M, van Gils F et al (2006): Information needs of early-stage prostate cancer patients: a comparison of seven European countries and Canada. European Society for Therapeutic Radiology and Oncology, October 2006, Leipzig, Germany, (Abstract) Feldman-Stewart D, Capirci C, Brennenstuhl S, Abacioglu U, Gawkowska-Suwinska M, van Gils F et al (2006): Information needs of early-stage prostate cancer patients: a comparison of seven European countries and Canada. European Society for Therapeutic Radiology and Oncology, October 2006, Leipzig, Germany, (Abstract)
21.
Zurück zum Zitat Gomella LG (2000) The wild, wild Web: resources for counseling patients with prostate cancer in the information age. Semin Urol Oncol 18:167–171PubMed Gomella LG (2000) The wild, wild Web: resources for counseling patients with prostate cancer in the information age. Semin Urol Oncol 18:167–171PubMed
22.
Zurück zum Zitat Gulavita S, Sinnott C, Setliff AE, Sellick SM (2000) Short report: what do men with prostate cancer what to know? Can Fam Phys 46:1769–1771 Gulavita S, Sinnott C, Setliff AE, Sellick SM (2000) Short report: what do men with prostate cancer what to know? Can Fam Phys 46:1769–1771
24.
Zurück zum Zitat Klotz LH, Nam RK (2006) Active surveillance with selective delayed intervention for favorable risk prostate cancer: clinical experience and a 'number needed to treat' analysis. Can J Urol 13:48–55PubMed Klotz LH, Nam RK (2006) Active surveillance with selective delayed intervention for favorable risk prostate cancer: clinical experience and a 'number needed to treat' analysis. Can J Urol 13:48–55PubMed
25.
Zurück zum Zitat Lintz K, Moynihan C, Steginga S, Norman A, Eeles R, Huddart R et al (2003) Prostate cancer patients' support and psychological care needs:survey from a non-surgical oncology clinic. Psychooncology 12:769–783. doi:10.1002/pon.702 PubMedCrossRef Lintz K, Moynihan C, Steginga S, Norman A, Eeles R, Huddart R et al (2003) Prostate cancer patients' support and psychological care needs:survey from a non-surgical oncology clinic. Psychooncology 12:769–783. doi:10.​1002/​pon.​702 PubMedCrossRef
29.
Zurück zum Zitat Soderdahl DW, Davis JW, Schellhammer PF, Given RW, Lynch DF, Shaves M et al (2005) Prospective longitudinal comparative study of health-related quality of life in patients undergoing invasive treatments for localized prostate cancer. J Endourol 19:318–326. doi:10.1089/end.2005.19.318 PubMedCrossRef Soderdahl DW, Davis JW, Schellhammer PF, Given RW, Lynch DF, Shaves M et al (2005) Prospective longitudinal comparative study of health-related quality of life in patients undergoing invasive treatments for localized prostate cancer. J Endourol 19:318–326. doi:10.​1089/​end.​2005.​19.​318 PubMedCrossRef
33.
Metadaten
Titel
Overall information needs of early-stage prostate cancer patients over a decade: highly variable and remarkably stable
verfasst von
Deb Feldman-Stewart
Sarah Brennenstuhl
Michael D. Brundage
D. Robert Siemens
Publikationsdatum
01.04.2009
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2009
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0514-1

Weitere Artikel der Ausgabe 4/2009

Supportive Care in Cancer 4/2009 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.